Skip to content

No transmission of integrase inhibitor-resistant HIV seen in California patients

New antiretrovirals and HIV treatment strategies highlighted at ICAAC

WHO guidelines recommend universal antiretroviral treatment, PrEP for those at substantial risk

Gottfried Hirnschall, director of WHO's Department of HIV/AIDS. Photo by Liz Highleyman, hivandhepatitis.com

High standards of care associated with reduced mortality risk of patients with HIV

Substantial improvement in life expectancy of older HIV-positive patients in modern treatment era, report Danes

Increasing levels of engagement with care is key to controlling HIV epidemic in US

Bone loss slows, but continues long-term in HIV-positive people on antiretroviral therapy

Asymptomatic neurocognitive impairment in people with HIV does predict later neurocognitive symptoms

Rilpivirine + darunavir HIV maintenance regimen matches standard three-drug antiretroviral therapy